Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor
Respiratory transmission is the primary route of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Angiotensin I converting enzyme 2 (ACE2) is the known receptor of SARS-CoV-2 surface spike glycoprotein for entry into human cells. A recent study reported absent to low expressio...
Main Authors: | Tamim Ahsan, Abu Ashfaqur Sajib |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-07-01
|
Series: | Biochemistry and Biophysics Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580821000765 |
Similar Items
-
SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets
by: Palur V Raghuvamsi, et al.
Published: (2021-02-01) -
Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction
by: Nardus Mollentze, et al.
Published: (2022-11-01) -
Interspecies transmission of SARS CoV-2 with special emphasis on viral mutations and ACE-2 receptor homology roles
by: Mervat E. Hamdy, et al.
Published: (2023-12-01) -
Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
by: Sai Priya Anand, et al.
Published: (2020-09-01) -
Proteomic Approach for Comparative Analysis of the Spike Protein of SARS-CoV-2 Omicron (B.1.1.529) Variant and Other Pango Lineages
by: Mukul Jain, et al.
Published: (2022-10-01)